This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Medical Practice  • Health Policy  • Medical Ethics  • Statistics and Research Methods  • Transplantation  • Transplantation, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Tracy Hampton, PhD

JAMA. 2006;296:2542-2543.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

New York—Rarely does an advance in scientific research have a major impact on medicine, ethics, religion, economics, and politics, but "the derivation of embryonic stem cells certainly has had such an effect even before much has been demonstrated with them," said John Gearhart, PhD, a pioneer in stem cell research.

Gearhart, of the Johns Hopkins University School of Medicine, in Baltimore, recently discussed the difficulties and potential solutions to supporting embryonic stem cell research with other scientists, advocates, and international policy leaders from the United States and the United Kingdom, as part of a public policy panel hosted by the not-for-profit New York Stem Cell Foundation. "Enormous" scientific and medical challenges confront scientists who hope to realize the therapeutic potential of embryonic stem cells, according to Gearhart.

A recent public policy panel hosted by the New York Stem Cell Foundation brought together scientists, advocates, and policy . . . [Full Text of this Article]

ADDRESSING CONTROVERSIES



CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?